The CIC-backed eye disease treatment developer has filed for a $100m initial public offering, having raised over $250m in funding in the past two years.

Oxford spinout Vaccitech, which developed the technology underlying the university’s covid vaccine, has filed for an offering on the Nasdaq Global Market.

The online learning platform developer spun out of Stanford University priced its shares at the top of their range.

Achilles Therapeutics has raised more than $175m in its initial public offering on the Nasdaq Global Select Market.

The vertical take-off and landing jet developer, an Unternehmertum spinout, is joining forces with the Nasdaq-listed Qell Acquisition Corp.

Lava Therapeutics, which is developing cancer treatments based on research at Amsterdam University Medical Centers, floated in a $101m offering.

The tissue analysis device maker, a spinout from Stanford University, has selected the Nasdaq Global Select Market for its initial public offering.

The University of Utah spinout is looking to float on the Nasdaq Global Select Market and has filed with a $100m placeholder amount.

Tokyo University of Science is set to exit the recruitment services group in an IPO in Tokyo.

UW Madison’s small-molecule therapy spinout has raised $170m in venture funding since emerging from stealth less than a year ago.